- Home
- RNA vs TGLS Comparison
RNA vs TGLS Comparison
Compare RNA & TGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- TGLS
- Stock Information
- Founded
- RNA 2012
- TGLS 1984
- Country
- RNA United States
- TGLS Colombia
- Employees
- RNA N/A
- TGLS N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- TGLS Electronic Components
- Sector
- RNA Health Care
- TGLS Consumer Discretionary
- Exchange
- RNA Nasdaq
- TGLS Nasdaq
- Market Cap
- RNA 3.7B
- TGLS 3.9B
- IPO Year
- RNA 2020
- TGLS 2012
- Fundamental
- Price
- RNA $31.12
- TGLS $69.22
- Analyst Decision
- RNA Strong Buy
- TGLS Buy
- Analyst Count
- RNA 10
- TGLS 5
- Target Price
- RNA $65.80
- TGLS $75.40
- AVG Volume (30 Days)
- RNA 1.3M
- TGLS 258.6K
- Earning Date
- RNA 03-07-2025
- TGLS 02-27-2025
- Dividend Yield
- RNA N/A
- TGLS 0.87%
- EPS Growth
- RNA N/A
- TGLS N/A
- EPS
- RNA N/A
- TGLS 3.20
- Revenue
- RNA $10,117,000.00
- TGLS $845,211,000.00
- Revenue This Year
- RNA N/A
- TGLS $8.94
- Revenue Next Year
- RNA N/A
- TGLS $10.39
- P/E Ratio
- RNA N/A
- TGLS $21.65
- Revenue Growth
- RNA N/A
- TGLS N/A
- 52 Week Low
- RNA $13.73
- TGLS $40.94
- 52 Week High
- RNA $56.00
- TGLS $86.99
- Technical
- Relative Strength Index (RSI)
- RNA 44.06
- TGLS 30.92
- Support Level
- RNA $31.14
- TGLS $73.12
- Resistance Level
- RNA $33.37
- TGLS $76.54
- Average True Range (ATR)
- RNA 1.67
- TGLS 2.13
- MACD
- RNA -0.16
- TGLS -0.73
- Stochastic Oscillator
- RNA 11.27
- TGLS 0.98
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
About TGLS Tecnoglass Inc.
Tecnoglass Inc designs, manufactures, distributes, and markets architectural glass and windows. The company's products portfolio includes tempered, laminated, insulating and Solar Control Low-E glass. Its products are installed at hotels, residential buildings, commercial and corporate centers, airports and hospitals as floating facades, curtain walls, windows, doors, handrails, interior and dividers. Its majority of revenue is derived from the sale and installation of architectural glass and windows in the United States.